Category: Hematology & Oncology
Global Hematology & Oncology
-
Research Antibodies Market Size, Trends, Analysis, and Outlook By Product(Primary Antibodies, Secondary Antibodies), By Type(Monoclonal Antibodies,Polyclonal Antibodies), By Technology(Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source(Mouse, Rabbit, Goat, Others), By Application(Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 The global Research Antibodies market size is poised to register ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
-
Single-cell Omics Market Size, Trends, Analysis, and Outlook By Product (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics), By Application (Oncology, Cell Biology, Neurology, Immunology), By End-user (Academic and Research Organizations, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... Hospital and Diagnostic Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Single-cell Omics market size is poised to register 18.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Cervical Cancers
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hematology Diagnostics Instruments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Veterinary Hematology Analyzers
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Veterinary Hematology Table Top Analyzers
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Hematology Instruments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immune-Oncology Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immuno Oncology Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Oncology Molecular Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hematology Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hematology Analyzers
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Precision Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tissue Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Acute Lymphoblastic Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cervical Dysplasia Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Diagnostic Tests for Cervical Dysplasia
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
Research Assistance
